Vita Life Sciences Limited's market cap is currently ―. The company's EPS TTM is AU$0.164; its P/E ratio is 14.24; and it has a dividend yield of 3.70%. Vita Life Sciences Limited is scheduled to report earnings on August 23, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 15.69M	AU$ 15.89M	AU$ 14.48M	AU$ 10.48M	AU$ 10.94M
Total Assets	AU$ 51.80M	AU$ 45.27M	AU$ 39.10M	AU$ 36.51M	AU$ 35.72M
Total Debt	AU$ 601.00K	AU$ 373.00K	AU$ 2.07M	AU$ 2.35M	AU$ 2.07M
Net Debt	AU$ -15.09M	AU$ -15.52M	AU$ -12.40M	AU$ -8.13M	AU$ -8.87M
Total Liabilities	AU$ 15.30M	AU$ 14.85M	AU$ 14.66M	AU$ 13.98M	AU$ 13.31M
Stockholders Equity	AU$ 36.57M	AU$ 30.75M	AU$ 24.72M	AU$ 22.60M	AU$ 22.38M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Vita Life Sciences Limited Earnings and Revenue History

Income Statement >

Vita Life Sciences Limited Debt to Assets

Balance Sheet >

Vita Life Sciences Limited Cash Flow

Cash Flow >

Vita Life Sciences Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing